... written between March 2004 and December 2006.
When reviewing applications to conduct cancer trials, the issue RECs are most likely to raise is that of informed consent. Committees are often concerned ...
Researchers running cancer trials are often critical of the Research Ethics Committee (REC) process they have to go through to get their trials approved, complaining that it's too complex, burdensome ...
... types, including breast cancer. Other breast cancer trials studying Iressa, either as a single ... impacted the accrual of the Arimidex-Iressa breast cancer study, said Cristofanilli. The study fell well ...
... just 16.6% joining clinical trials between April 2005 and March 2008, compared ... closer dialogue between research groups when they are planning cancer trials. They should give particular consideration ...
... research," Sherman said. "This is the first of the various thyroid cancer trials to identify specific mutations that might ... typically has about 80 Phase I clinical trials under way, testing new targeted ...
Across the country 800 terminally ill men and women have agreed to be human guinea pigs in a hunt for new cancer drugs
... called telomerase is considered the holy grail of cancer research. Her research has allowed us to ... leads the Australian New Zealand Breast Cancer Trials Group, recognised as one of the premier breast ...
... treated 672 women whose ovarian cancer had progressed after first-line treatment. Half the ... tissue sarcoma. In addition to the phase III ovarian cancer trial, it is being studied in smaller, phase II ...
... Iressa in Non-small cell lung cancer Trial Evaluating REsponse and Survival versus ... overall prognostic survival markers for lung cancer, but not predictive to treatment with either therapy.
"Our study ...
... he says. "While a three percent difference in cancer recurrence may not seem like much, it can mean ... tamoxifen. AIOG is a subset of the Early Breast Cancer Trials Collaborative Group (EBCTCG), a global ...
... criteria will affect all clinicians who are running clinical cancer trials. RECIST 1.1 describes ... M. Eggermont, president of ECCO (the European CanCer Organisation), welcomed the publication of RECIST 1 ...
... in three clinical trials that are currently active. In the ovarian cancer trial, the furthest advanced; evidence of biologic activity has been noted in refractory ovarian cancer patients.
The ...
Results from early-stage colon cancer trial turn spotlight on recent acquisition.
... would result in a diagnosis of high-grade cancer—and the more likely a high PSA level would ... Presti, who is a member of Stanford's Cancer Center.
The original cancer trial researchers reached similar ...
Canadians interested in learning about clinical cancer trials or connecting with others in their area affected by the disease can now access a new online resource.
